LRRK2 and Parkinson disease: Based on our baseline results and the variability in disease progression in patients with LRRK2 G2019S associated PD, it is reasonable to assume that some phenotypic expression of the mutation may become apparent only following a significant or stressful challenge (Benson et al., 2018).